HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea · Delayed Price · Currency is KRW 2,405.00
-145.00 (-5.69%)
Sep 18, 2026, 3:30 PM KST
HLB Life Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10,107 | 13,291 | 52,725 | 16,769 | 30,978 | 31,254 |
Short-Term Investments | 4,472 | 586.88 | 16,212 | 11,298 | 12,350 | 24,690 |
Trading Asset Securities | - | - | 10,629 | 50,793 | 88,661 | 84,017 |
Cash & Short-Term Investments | 14,578 | 13,878 | 79,566 | 78,860 | 131,989 | 139,961 |
Cash Growth | -61.00% | -82.56% | 0.90% | -40.25% | -5.70% | -11.44% |
Accounts Receivable | 17,992 | 14,975 | 18,120 | 11,464 | 13,072 | 11,648 |
Other Receivables | 1,084 | 1,906 | 2,057 | 2,371 | 2,116 | 1,123 |
Receivables | 20,085 | 22,884 | 20,188 | 14,646 | 16,202 | 14,157 |
Inventory | 7,822 | 6,791 | 6,103 | 5,267 | 10,867 | 1,769 |
Prepaid Expenses | 1,408 | 1,081 | 468.69 | 448.74 | 208.4 | 281.34 |
Other Current Assets | 1,362 | 1,004 | 1,382 | 238.85 | 1,509 | 654.91 |
Total Current Assets | 45,256 | 45,637 | 107,709 | 99,460 | 160,776 | 156,822 |
Property, Plant & Equipment | 130,032 | 129,753 | 81,206 | 72,918 | 92,089 | 22,081 |
Long-Term Investments | 217,135 | 226,153 | 254,694 | 146,038 | 44,749 | 24,346 |
Goodwill | - | 8,275 | - | 1,772 | 21,925 | - |
Other Intangible Assets | 51,205 | 43,338 | 44,780 | 54,029 | 69,506 | 62,809 |
Long-Term Accounts Receivable | - | - | - | - | 341.17 | 363.96 |
Long-Term Deferred Charges | - | 125.91 | - | - | - | - |
Other Long-Term Assets | 24,615 | 24,676 | 50,500 | 49,158 | 22,264 | 4,262 |
Total Assets | 468,399 | 478,094 | 539,017 | 423,500 | 411,790 | 270,800 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4,270 | 2,682 | 6,985 | 5,160 | 9,384 | 10,278 |
Accrued Expenses | 2,973 | 2,819 | 2,029 | 2,240 | 697.15 | 717.82 |
Short-Term Debt | 73,190 | 84,727 | 28,153 | 106,761 | 7,920 | - |
Current Portion of Long-Term Debt | 23,582 | 18,380 | 12,276 | 7,060 | 387.2 | - |
Current Portion of Leases | 868.21 | 920.17 | 632.14 | 922.33 | 2,145 | 668 |
Current Income Taxes Payable | - | 177.53 | 52.6 | 7,555 | 132.13 | - |
Current Unearned Revenue | - | - | 2.91 | 31.49 | 38.42 | 24.01 |
Other Current Liabilities | 14,339 | 9,111 | 3,417 | 5,727 | 6,081 | 1,848 |
Total Current Liabilities | 119,222 | 118,815 | 53,547 | 135,457 | 26,785 | 13,536 |
Long-Term Debt | 59,949 | 54,473 | 82,529 | 51,410 | 136,189 | 3,500 |
Long-Term Leases | 1,657 | 1,857 | 193.33 | 424.01 | 832.41 | 452.62 |
Pension & Post-Retirement Benefits | 723.45 | 709.14 | 568.2 | 615.57 | 683.58 | 716.65 |
Long-Term Deferred Tax Liabilities | 2,192 | 2,208 | 2,310 | 3,345 | 10,033 | 5,758 |
Other Long-Term Liabilities | 2,193 | 2,288 | 1,045 | 1,036 | 1,201 | 224.73 |
Total Liabilities | 185,937 | 180,351 | 140,192 | 192,288 | 175,724 | 24,188 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 61,432 | 61,432 | 61,416 | 51,407 | 48,831 | 48,223 |
Additional Paid-In Capital | 320,795 | 320,197 | 319,343 | 168,141 | 222,910 | 240,895 |
Retained Earnings | -99,916 | -83,416 | 16,373 | 10,431 | -40,963 | -46,832 |
Treasury Stock | -679.97 | -679.97 | -679.97 | -679.97 | - | - |
Comprehensive Income & Other | 431.26 | -182 | 1,889 | 1,499 | 3,947 | 3,904 |
Total Common Equity | 282,063 | 297,351 | 398,340 | 230,797 | 234,725 | 246,189 |
Minority Interest | 398.93 | 390.84 | 484.91 | 416.21 | 1,342 | 422.87 |
Shareholders' Equity | 282,462 | 297,742 | 398,825 | 231,213 | 236,067 | 246,612 |
Total Liabilities & Equity | 468,399 | 478,094 | 539,017 | 423,500 | 411,790 | 270,800 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 159,246 | 160,357 | 123,783 | 166,578 | 147,473 | 4,621 |
Net Cash (Debt) | -144,668 | -146,479 | -44,217 | -87,718 | -15,484 | 135,340 |
Net Cash Growth | - | - | - | - | - | -7.71% |
Net Cash Per Share | -1187.46 | -1201.75 | -396.21 | -861.84 | -153.36 | 1362.33 |
Filing Date Shares Outstanding | 121.85 | 121.85 | 121.81 | 101.8 | 96.71 | 100.44 |
Total Common Shares Outstanding | 121.85 | 121.85 | 121.81 | 101.8 | 101.71 | 100.44 |
Working Capital | -73,966 | -73,179 | 54,162 | -35,997 | 133,991 | 143,286 |
Book Value Per Share | 2314.89 | 2440.36 | 3270.06 | 2267.23 | 2307.67 | 2451.22 |
Tangible Book Value | 230,857 | 245,738 | 353,561 | 174,996 | 143,294 | 183,380 |
Tangible Book Value Per Share | 1894.65 | 2016.78 | 2902.45 | 1719.07 | 1408.78 | 1825.85 |
Land | - | 27,490 | 21,569 | 21,471 | 29,580 | 9,065 |
Buildings | - | 51,362 | 23,221 | 23,221 | 19,950 | 4,547 |
Machinery | - | 75,805 | 40,056 | 39,219 | 30,949 | 12,906 |
Construction In Progress | - | 1,243 | 33,101 | 8,472 | 18,390 | 1,324 |